CELLnLIFE Inc announced that it has received Series B round of funding on May 31, 2021. The transaction included participation from Quratis Inc., GAMEVIL Inc. (KOSDAQ:A063080), QuantaMatrix Inc. (KOSDAQ:A317690).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,900 KRW | +0.13% | +6.56% | -16.31% |
1st Jan change | Capi. | |
---|---|---|
-16.31% | 46.61M | |
-9.59% | 7.67B | |
-1.20% | 5.41B | |
+26.10% | 4.62B | |
+0.02% | 4.57B | |
-53.02% | 3.22B | |
+6.42% | 2.59B | |
-14.95% | 2.05B | |
-8.29% | 1.79B | |
+0.42% | 1.76B |
- Stock Market
- Equities
- A317690 Stock
- News QuantaMatrix Inc.
- CELLnLIFE Inc announced that it has received funding from Quratis Inc., GAMEVIL Inc., QuantaMatrix Inc.